⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MDCX News
Medicus Pharma Ltd. Common Stock
Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome
globenewswire.com
MDCX
New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA
accessnewswire.com
COCH
DVLT
RDZN
MDCX
IGC
Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program
globenewswire.com
MDCX
Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission
globenewswire.com
MDCX
New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET
accessnewswire.com
COCH
GROY
DVLT
LTRN
MDCX
RDZN
CAST
Form 8-K
sec.gov
MDCXW
MDCX
Medicus Pharma Advances SkinJect® into Registrational Development for Gorlin Syndrome
globenewswire.com
MDCX
New to The Street Broadcasts Nationwide on Bloomberg Television Featuring "Opportunities To Consider(TM)" Across Artificial Intelligence, Healthcare Innovation, Fintech, Digital Assets, and Commodities
accessnewswire.com
LTRN
RDZN
HIT
DVLT
GROY
MDCX
IGC
Medicus Pharma Announces $22 Million Non-Dilutive Financing
globenewswire.com
MDCX
Form 8-K
sec.gov
MDCX
MDCXW